All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Listed as ongoing, but also has a completion date | 2007-005100-41 | Phase I/II/III Pharmacokinetic and Outcome Study of Inspiration's Recombinant Factor IX Product, IB1001, in Subjects with Hemophilia B | 2016-12-31 | bad-data |
| Listed as ongoing, but also has a completion date | 2010-024190-39 | Study of Inspiration’s Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects with Hemophilia B | 2016-12-31 | bad-data |
| Reported results | 2011-000181-34 | Efficacy and Safety of B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies | 2014-01-28 | due-trials |